Cargando…

Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 acts as a new biomarker for NSTEMI and STEMI patients

OBJECTIVE: The diagnostic significance of plasma soluble lectin-like oxidized low-density lipoprotein receptor-1(sLOX-1) for non-ST segment elevated myocardial infarction (NSTEMI) and ST segment elevated myocardial infarction (STEMI) were explored by this study. METHODS: In this study, 107 acute NST...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sheikh, Md Sayed Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993255/ https://www.ncbi.nlm.nih.gov/pubmed/36910399 http://dx.doi.org/10.4314/ahs.v22i3.37

Ejemplares similares

Role of Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and microRNA-98 in Severity and Risk of Coronary Artery Disease
por: Sheikh, Md Sayed Ali
Publicado: (2021)

Analysis of STEMI and NSTEMI in a Community Cohort of Marijuana Users
por: Jean-Louis, Farla, et al.
Publicado: (2022)

Serum Lectin-Like Oxidized-Low Density Lipoprotein Receptor-1 and Adiponectin Levels Are Associated With Coronary Artery Disease Accompanied With Metabolic Syndrome
por: Md Sayed, Ali Sheikh, et al.
Publicado: (2014)

Late STEMI and NSTEMI Patients’ Emergency Calling in COVID-19 Outbreak
por: Trabattoni, Daniela, et al.
Publicado: (2020)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Is Inversely Correlated with the Activity of ANCA-Associated Vasculitis
por: Yoon, Taejun, et al.
Publicado: (2020)

Serum soluble lectin‐like oxidized low‐density lipoprotein receptor‐1 as a biomarker of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
por: Lin, Qun, et al.
Publicado: (2020)

Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon
por: Caglar, Ilker Murat, et al.
Publicado: (2016)

Predictors of Long-Term Outcome in STEMI and NSTEMI—Insights from J-MINUET
por: Lechner, Ivan, et al.
Publicado: (2020)

High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity
por: Stinson, Sara E., et al.
Publicado: (2023)

Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development
por: Žaliaduonytė-Pekšienė, Diana, et al.
Publicado: (2017)

Using the Gensini score to estimate severity of STEMI, NSTEMI, unstable angina, and anginal syndrome
por: Charach, Lior, et al.
Publicado: (2021)

Role of Lectin-Like Oxidized Low Density Lipoprotein-1 in Fetoplacental Vascular Dysfunction in Preeclampsia
por: Zuniga, Felipe A., et al.
Publicado: (2014)

Pregnancy Followed by Delivery May Affect Circulating Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels in Women of Reproductive Age
por: Balin, Mehmet, et al.
Publicado: (2012)

High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study
por: Yokota, Chiaki, et al.
Publicado: (2016)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Level is Related to Clinical Prognosis In Patients with Acute Atherosclerosis-related Ischemic Stroke
por: Yang, Xiaoli, et al.
Publicado: (2021)

Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease
por: Kott, Katharine A., et al.
Publicado: (2023)

Lectin-like oxidized low-density lipoprotein receptor 1 attenuates pneumonia-induced lung injury
por: Korkmaz, Filiz T., et al.
Publicado: (2022)

Synthesized 18-Lead Electrocardiogram in Diagnosing Posterior Stemi-Equivalent Acute Coronary Syndrome in Patients with NSTEMI
por: Horie, Tomoki, et al.
Publicado: (2022)

Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome
por: Stankova, Teodora, et al.
Publicado: (2019)

Association of circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 with inflammatory markers and urinary albumin excretion in patients with type 2 diabetes
por: Takebayashi, Kohzo, et al.
Publicado: (2021)

Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI)
por: Aladağ, Nesim, et al.
Publicado: (2021)

Inhibition of the lectin-like oxidized low-density lipoprotein receptor-1 improves intestinal microcirculation in experimental endotoxaemia
por: Lehmann, C, et al.
Publicado: (2009)

Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome
por: Kumar, Sandeep, et al.
Publicado: (2021)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020)

Shock index and modified shock index are predictors of long-term mortality not only in STEMI but also in NSTEMI patients
por: Schmitz, Timo, et al.
Publicado: (2022)

Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction
por: Takeji, Yasuaki, et al.
Publicado: (2021)

DID THE COVID-19 PANDEMIC CAUSE PATIENTS WITH TYPE I STEMI OR NSTEMI TO DELAY SEEKING MEDICAL ATTENTION?
por: Wagle, Sugat, et al.
Publicado: (2022)

Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1
por: Mentrup, Torben, et al.
Publicado: (2021)

Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack
por: Skarpengland, Tonje, et al.
Publicado: (2018)

Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
por: Vavere, Andrea L., et al.
Publicado: (2023)

Health-Related Quality-of-Life after Percutaneous Coronary Intervention in Patients with UA/NSTEMI and STEMI: the Korean Multicenter Registry
por: Kim, Mi-Jeong, et al.
Publicado: (2013)

Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study
por: Adamski, Piotr, et al.
Publicado: (2017)

Hospital admissions and mortality for STEMI and NSTEMI during COVID-19 outbreak: a meta-analysis: Paolo Matteo Angeletti
por: Altobelli, E, et al.
Publicado: (2022)

Lectin-like, oxidized low-density lipoprotein receptor-1-deficient mice show resistance to age-related knee osteoarthritis
por: Hashimoto, Kazuhiko, et al.
Publicado: (2017)

Correction to: Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
Publicado: (2023)

Soluble lectin‐like oxidized low‐density Lipoproteinreceptor‐1 and recurrent stroke: A nested case–control study
por: Wang, Anxin, et al.
Publicado: (2022)

Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention
por: Liu, Junfeng, et al.
Publicado: (2018)

Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry
por: Sherwood, Matthew W., et al.
Publicado: (2014)

Acute Pulmonary Edema and NSTEMI
por: Pilgrim, Ashley
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h6r353qiil3an5nvr60ojpj6fu